Clinical Trial Update: A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating pharmacokinetics, effectiveness, and safety of Afimkibart for induction and maintenance therapy in children with mode…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Afimkibart (RO7790121)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Moderately to Severely Active Crohns Disease | Phase 3 | Status: NOT_YET_RECRUITING